Ab Initio Pharma partners with Consumer Healthcare Company VBreathe.

Ab Initio is pleased to announce that it has partnered with VBreathe, a Consumer Healthcare company, to aid in the development of an innovative new product line.

Dr Hui Xin Ong (Director, Ab Initio) and Mohit Sharma (CEO, Vbreathe)

VBreathe, an Australian owned consumer healthcare company produces an award winning intelligent and portable indoor air purifier and detoxifier that removes airborne microbes, including mold, fungal spores, dust mites and bacteria. The VBreathe Tasman is the company’s first product, winning Gold in the Good Design Awards 2020. It has been tested by leading laboratories and is available to consumers globally.

Ab Initio Pharma, is an Australian owned pharmaceutical company, who manufacture and design therapeutic products with a specialisation in aerosols. Based in Sydney, Ab Initio has state of the art facilities to develop and test new consumer healthcare products and has partnered with VBreathe to ensure continued innovation in the area of air purification and detoxification.

With recent success in the NSW District Innovation Challenge, VBreathe and Ab Initio will partner to develop an advanced VBreathe anti-viral air filtration personal device that will fight the war against COVID and future infection.

Dr. Hui Xin Ong, Director of Ab Initio, commented: 'When VBreathe approached us about this exciting venture, we instantly saw how this aligns with our company’s values and scientific expertise. The Team at Ab Initio have decades of experience in evaluating airborne particulates and their effect on the human body at a cellular level. At our state-of-the-art R&D facility in Sydney, we have the tools necessary to develop innovative solutions to fight COVID and other viruses that can benefit mankind'

Mohit Sharma, CEO of VBreathe commented: 'On the back of our already successful Tasman Air purification and Detoxification system, as well as recent recognition by the NSW Government's Innovation award we are well placed to continue innovating in this space. Ab Initio were the natural partners for us based on their skills andtechnical expertise. We look forward to working closely with them' .